Cite
HARVARD Citation
Cho, H. et al. (2017). Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib. Cytokine. pp. 118-125. [Online].